# Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults

> **NCT05547438** · PHASE1 · UNKNOWN · sponsor: **NeuroTrauma Sciences, LLC** · enrollment: 32 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** NTS-104 TRIS
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05547438
- **Lead sponsor:** NeuroTrauma Sciences, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-28
- **Primary completion:** 2023-07-27
- **Final completion:** 2023-08-07
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2023-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05547438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05547438, "Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05547438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*